An efficient extraction method from blood clots for studies requiring both host and viral DNA.

Basuni AA, Butterworth LA, Cooksley G, Locarnini S and Carman WF. 2000.
J. Viral Hepatol. 7:241-243.

Molecular analysis of human immunodeficiency virus strains associated with a case of criminal transmission of the virus.

Birch CJ, McCaw RF, Bulach DM, Revill P, Carter JT, Tomnay J, Hatch B, Middleton T, Chibo D, Catton M, Pankhurst J, Breschkin AM, Locarnini SA and Bowden DS. 2000.
J. Infect. Dis. 182: 941-944.

Molecular characterisation of measles viruses isolated in Victoria, Australia, between 1973 and 1998.

Chibo D, Birch C, Rota PA and Catton M. 2000.
J. Gen. Virol. 81: 2511-2518.

In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.

Colledge D, Civitico G, Locarnini S and Shaw T. 2000.
Antimicrob. Agents Chem. 44:551-560.

Minimising harm from hepatitis C virus needs better strategies.

Crofts N, Caruana S, Bowden S and Kerger M. 2000.
BMJ 321: 899.

Current methods for the disinfectant inactivation of HIV.

Druce J and Birch C. 2000.
Australian Microbiology 21: 18-22.

Poliomyelitis eradication in Australia.

D'Souza R, Kennett M, Prasopa-Plaizier N, Kelly H, Halliday L and Watson C. 2000.
National documentation for certification of poliomyelitis eradication in Australia. Canberra: Commonwealth of Australia.

Legionnaires' disease outbreak: Victoria's largest identified outbreak.

Formica N, Tallis N, Zwolak B, Beers M, Hogg G, Ryan N and Yates M) 2000.
CDI 24:199-202

Evidence for late stage compartmentalization of HIV-1 resistance mutations between lymph node and peripheral blood mononuclear cells.

Haddad DN, Birch C, Middleton T, Dwyer DE, Cunningham AL and Saksena N. 2000.
AIDS 14:2273-2281.

Effect of Protease inhibitors on HIV-1 maturation and infectivity.

Jardine DK, Tyssen DP and Birch C. 2000.
Antiviral Research 45:59-68.

Laboratory-supported influenza surveillance in Victorian sentinel general practices.

Kelly H, Murphy A, Leong W, Leydon J, Tresise P, Gerrard M, Chibo D, Birch C, Andrews R and Catton M. 2000.
Communicable Diseases Intelligence 24:379-383.

Laboratory containment of wild poliovirus in Australia.

Kelly H, Prasopa-Plaizier N, Soar A, Sam G and Kennett M. 2000.
Communicable Diseases Intelligence 24:207- 210.

The age-specific prevalence of susceptibility to human parvovirus in Victoria, Australia and other parts of the world.

Kelly H, Hammond R, Leydon J, Siebert D, Kiely P and Maskill W. 2000.
Epidemiology and Infection 124:449-457.

Report of the Australian National Polio Reference Laboratory. 1 January 1999 to 30 June 1999. Towards WHO certification as wild poliovirus free: laboratory surveillance in Australia.

Kennett M, Stambos V, Turnbull A, Ibrahim A and Kelly H. 2000.
Communicable Diseases Intelligence 23:324-327.

Enhanced measles surveillance during an inter-epidemic period in Victoria.

Lambert SB, Kelly HA, Andrews RM, Catton MG, Lynch PA, Leydon JA, Gercovich DK, Hogg GG, Morgan MA and Lester RA. 2000.
Med. J. Aust. 172:114-118.

Measles outbreak in young adults in Victoria, 1999.

Lambert S, Morgan M, Riddell M, Andrews R, Kelly H, Leydon J, Catton M, Lynch P, Gercovich D, Lester R, Carnie J and Rouch G. 2000.
Med. J. Aust. 173: 467-471.

Visualisation of phenotypically mixed HIV-1 and HTLV-1 virus particles by electron microscopy.

Lawson VA, Lee J-Y, Doultree JC, Marshall JA and McPhee DA. 2000.
J. Biomed. Sci. 7:71-74.

Rubella virus: viral replication and links to teratogenicity.

Lee JY and Bowden DS. 2000.
Clin. Microbiol. Rev. 13: 571-587.

Recombinant subunit ORF2.1 antigen induces antibody against immunodominant epitopes in the hepatitis E virus capsid protein.

Li F, Riddell M, Seow H -F, Takeda N, Miyamura T and Anderson DA. 2000.
J. Med. Virol. 60:379-386

A virological perspective on the need for vaccination.

Locarnini S. 2000.
J. Viral Hepatitis 7 (Suppl.1):5-6.

Molecular pathogenesis of viral hepatitis.

Locarnini S. 2000.
J. Gastroenterol. & Hepatol. 15:546-548.

Assays for measuring hepadnaviral supercoiled DNA.

Locarnini SA and Civitico GM. 2000.
Methods in Molecular Medicine, Antiviral Methods & Protocols. eds. D Kinchington and R Schinazi, pp.77-86.

Multiple outbreaks of Norwalk-like virus gastroenteritis associated with a Mediterranean-style restaurant.

Marshall J,Yuen L, Catton M, Gunesekere I, Wright P, Bettelheim K, Griffith J, Lightfoot D, Hogg G, Gregory J, Whitby R and Gaston J. 2000.
J. Med. Micro. 50:143-160.

Detection of astrovirus gastroenteritis in children.

McIver CJ, Palumbo EA, Doultree JC, Mustafa H, Marshall JA, and Rawlinson WD. 2000.
J. Virol. Methods 84:99-105.

Effects of corticosteroid and nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.

Nicoll A, Locarnini S, Chou ST, Smallwood R and Angus P. 2000.
J. Gastroenterol. & Hepatol. 15:304-310.

Perception of social value predicts participation in school-based research.

Pound B, Riddell M, Byrnes G and Kelly H. 2000.
Aust. NZ J. Public Health 24(5):543-545.

Detection of measles RNA during a measles epidemic: an investigation of optimal specimen type and sampling time.

Riddell M, Chibo D, Kelly H, Catton M and Birch C. 2000.
J. Clin. Microbiol. 39:375-376.

Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.

Riddell MA, Li F and Anderson DA. 2000.
J. Virol. 74:8011-8017.

Assessment of long term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971-1975.

Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T and Crofts N. 2000.
Hepatology 32:582- 587.

Legionella outbreak: the VIDRL perspective.

Ryan N, Leydon J and Kelly H. 2000.
Victorian Infectious Diseases Bulletin 3:19-20.

Combination chemotherapy for the treatment of chronic hepatitis B virus: the path forward?

Shaw T and Locarnini S. 2000.
Drugs 60:517-531.

Combination chemotherapy for hepatitis B virus: The final solution?

Shaw T and Locarnini S. 2000.
Hepatology 32:430-432.

Assays for hepatitis B virus DNA- and RNA-dependent DNA polymerase activities.

Shaw T and Locarnini S. 2000.
Methods in Molecular Medicine, Antiviral Methods & Protocols. eds. D Kinchington and R Schinazi pp.87-88.

A probable new species of Helicobacter isolated from a patient with bacteraemia.

Tee W, Hinds S, Montgomery J and Dyall-Smith M. 2000.
J. Clin. Microbiol. 38: 3846- 3848.

Synthesis, stability, antiviral activity and protease-bound structures of substrate-mimicking, constrained macrocyclic inhibitors of HIV-1 protease.

Tyndall JDA, Reid RC, Tyssen DP, Jardine DK, Todd B, Passmore M, March DR, Pattenden LK, Alewood D, Shuhong H, Alewood PF, Birch CJ, Martin JL and Fairlie DP. 2000.
J. Med.Chem. 43:3495-3504.

Antiviral chemotherapy for the treatment of hepatitis B virus infections.

Torresi J and Locarnini S. 2000
Gastroenterology 118 (Suppl 2):83-103.

The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu.

Wilson N, Ruff TA, Rana BJ, Leydon J and Locarnini S. 2000.
Vaccine 18:3059-3066.